105 related articles for article (PubMed ID: 217544)
1. Characterization of cross-reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cells.
Thorley-Lawson DA
Cell; 1979 Jan; 16(1):33-42. PubMed ID: 217544
[TBL] [Abstract][Full Text] [Related]
2. Polypeptides of the Epstein-Barr virus membrane antigen complex.
Thorley-Lawson DA; Edson CM
J Virol; 1979 Nov; 32(2):458-67. PubMed ID: 228070
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen.
Hoffman GJ; Lazarowitz SG; Hayward SD
Proc Natl Acad Sci U S A; 1980 May; 77(5):2979-83. PubMed ID: 6248876
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus membrane antigens: characterization, distribution, and strain differences.
Edson CM; Thorley-Lawson DA
J Virol; 1981 Jul; 39(1):172-84. PubMed ID: 6268807
[TBL] [Abstract][Full Text] [Related]
5. Identification of Epstein-Barr virus strain differences with monoclonal antibody to a membrane glycoprotein.
Qualtiere LF; Chase R; Vroman B; Pearson GR
Proc Natl Acad Sci U S A; 1982 Jan; 79(2):616-20. PubMed ID: 6176998
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220.
Sairenji T; Bertoni G; Medveczky MM; Medveczky PG; Nguyen QV; Humphreys RE
J Virol; 1988 Aug; 62(8):2614-21. PubMed ID: 2839689
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus strain- and group-specific antigenic determinants detected by monoclonal antibodies.
Mueller-Lantzsch N; Georg-Fries B; Herbst H; zur Hausen H; Braun DG
Int J Cancer; 1981 Sep; 28(3):321-7. PubMed ID: 6172392
[TBL] [Abstract][Full Text] [Related]
8. Production of monoclonal antibody to a late intracellular Epstein-Barr virus-induced antigen.
Kishishita M; Luka J; Vroman B; Poduslo JF; Pearson GR
Virology; 1984 Mar; 133(2):363-75. PubMed ID: 6324457
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity.
Thorley-Lawson DA; Geilinger K
Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5307-11. PubMed ID: 6254073
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of Epstein-Barr virus-related surface polypeptides expressed on n-butyrate-treated P3HR-1 cells.
Kawanishi M; Sugawara K; Ito Y
Intervirology; 1983; 19(3):162-8. PubMed ID: 6299996
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel EBV-induced membrane glycoprotein of 43 kDa with H667 MAb.
Sanchez-Pinel A; Bernad J; Rives H; Lapchine L; Icart J; Didier J
Virology; 1991 Jan; 180(1):31-40. PubMed ID: 1845828
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells.
Rowe M; Evans HS; Young LS; Hennessy K; Kieff E; Rickinson AB
J Gen Virol; 1987 Jun; 68 ( Pt 6)():1575-86. PubMed ID: 2438376
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid.
Summers WC; Klein G
J Virol; 1976 Apr; 18(1):151-5. PubMed ID: 176457
[TBL] [Abstract][Full Text] [Related]
14. Quantification of an Epstein-Barr virus-associated membrane antigen component.
North JR; Morgan AJ; Thompson JL; Epstein MA
J Virol Methods; 1982 Sep; 5(1):55-65. PubMed ID: 6292251
[TBL] [Abstract][Full Text] [Related]
15. Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines.
Gerber P; Ablashi D; Magrath I; Armstrong G; Andersen P; Trach L
J Natl Cancer Inst; 1982 Sep; 69(3):585-90. PubMed ID: 6287082
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody specific for capsid antigen of Epstein-Barr virus.
Takada K; Fujiwara S; Yano S; Osato T
Med Microbiol Immunol; 1983; 171(4):225-31. PubMed ID: 6304479
[TBL] [Abstract][Full Text] [Related]
17. A solid-phase radioimmunoassay for Epstein-Barr virus-associated membrane antigen prepared from B95-8 cell culture supernatants.
Dölken G; Klein G
J Natl Cancer Inst; 1977 May; 58(5):1239-45. PubMed ID: 192896
[TBL] [Abstract][Full Text] [Related]
18. Radioimmune precipitation study comparing the Epstein-Barr virus membrane antigens expressed on P3HR-1 virus-superinfected Raji cells to those expressed on cells in a B-95 virus-transformed producer culture activated with tumor-promoting agent (TPA).
Qualtiere LF; Pearson GR
Virology; 1980 Apr; 102(2):360-9. PubMed ID: 6245514
[No Abstract] [Full Text] [Related]
19. Observations on the EB virus envelope and virus-determined membrane antigen (MA) polypeptides.
North JR; Morgan AJ; Epstein MA
Int J Cancer; 1980 Aug; 26(2):231-40. PubMed ID: 6162806
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of a surface antigen on Epstein-Barr virus genome-carrying lymphoid cells: distinction from the virus-determined membrane antigen.
Sakamoto K; Hinuma Y
J Immunol; 1978 May; 120(5):1702-8. PubMed ID: 207776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
